The PED ShopThe PED Shop Shop
Retatrutide vs Tirzepatide

Retatrutide vs Tirzepatide

Retatrutide and Tirzepatide are compared here on the things that actually differ between them: what class each belongs to, what each acts on, how each is supplied and what each costs per milligram. Where the registry has no figure for one of them the row is left out rather than filled in.

4Retatrutide listings
4Tirzepatide listings
Reference only. This page covers what the compound is, how it is presented and how it is handled. It does not give dosing protocols or administration schedules, and it is not medical advice.

Side by side

RetatrutideTirzepatide
ClassTriple GIP/GLP-1/glucagon receptor agonistDual GIP/GLP-1 receptor agonist
Acts onA single peptide with agonist activity at three receptors: GIP, GLP-1 and glucagon. The glucagon component is what distinguishes it from dual agonists such as tirzepatide.Agonist at both the GIP and GLP-1 receptors, a mechanism distinct from single-receptor GLP-1 agonists such as semaglutide.
Supplied asLyophilised vial, or pre-filled pen graduated in dial units.Lyophilised vial or pre-filled pen.
Half-lifeLong, supporting weekly intervals in clinical study design.Approximately five days in published pharmacokinetics.
StorageRefrigerated. Pens must not be frozen. Protect from light.Refrigerated, protected from light. Not to be frozen.
Listings44
Price from£160£110

What actually differs

The clearest difference is class: Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist, Tirzepatide is a dual GIP/GLP-1 receptor agonist. They are not supplied the same way. Retatrutide comes as a lyophilised vial, or pre-filled pen graduated in dial units, Tirzepatide as a lyophilised vial or pre-filled pen. Half-life differs as well: Long, supporting weekly intervals in clinical study design for Retatrutide against Approximately five days in published pharmacokinetics for Tirzepatide.

Stocked at The PED Shop

Availability checked 2026-09-09. The product page carries live stock.

Brands stockedQUANTASerenQ